Clearside Biomedical, Inc.CLSDNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q3 2025 | -9.76% |
| Q2 2025 | -4.89% |
| Q1 2025 | -16.51% |
| Q4 2024 | -10.06% |
| Q3 2024 | -22.97% |
| Q2 2024 | -21.22% |
| Q1 2024 | -22.45% |
| Q4 2023 | -23.00% |
| Q3 2023 | -157.00% |
| Q2 2023 | -282.74% |
| Q1 2023 | -74.86% |
| Q4 2022 | -43.02% |
| Q3 2022 | -26.65% |
| Q2 2022 | -20.41% |
| Q1 2022 | -17.06% |
| Q4 2021 | 112.07% |
| Q3 2021 | -10.39% |
| Q2 2021 | 12.46% |
| Q1 2021 | 66.67% |
| Q4 2020 | 3.31% |
| Q3 2020 | 7.30% |
| Q2 2020 | -30.91% |
| Q1 2020 | -11.36% |
| Q4 2019 | 3.59% |
| Q3 2019 | -25.89% |
| Q2 2019 | -27.26% |
| Q1 2019 | -36.07% |
| Q4 2018 | -46.45% |
| Q3 2018 | -33.98% |
| Q2 2018 | -34.93% |
| Q1 2018 | 279.24% |
| Q4 2017 | -41.97% |
| Q3 2017 | -32.16% |
| Q2 2017 | -19.30% |
| Q1 2017 | -20.75% |
| Q4 2016 | 223.72% |
| Q3 2016 | -148.73% |
| Q2 2016 | 1555.22% |
| Q1 2016 | 111.26% |
| Q4 2015 | -16.16% |